DEBUG: PAGE=domain, TITLE=Healthcare & Pharmaceuticals,ID=1436,TEMPLATE=bpomarket
toggle expanded view

Search within: Healthcare & Pharmaceuticals:

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

Tech Mahindra Announces Q1 FY22 Revenues Up 14.6% (Up 10.8% CC) to $1,384m

Financial Results

by

published on Jul 30, 2021

Tech Mahindra has announced its Q1 FY22, the period ending June 30, 2021:

Q1 FY22:

  • Revenues were $1,383.6m, up 14.6% y/y and up 10.8% y/y at cc
  • EBIT was $209m, a margin of 15.1%, up 5.1 pts.

Q1 FY22 NH revenue estimate (and y/y revenue growth) by vertical was:

  • Communications: $553m (+12.6%, +7.8% at CC)
  • Manufacturing: $124m (+12.2%)
  • Technology, media & entertainment: $122 (+2%)
  • BFSI: $227m (+19.7%)
  • Retail, transport & logistics: $107m (+16.4%)
  • Others: $147m (+11%).

Q1 FY22 NH revenue estimate (and y/y revenue growth) by geography was:

  • Americas: $645m (+8.4%)
  • Europe: $376m (+20.5%)
  • Rest of the world: $361m (+20.7%).

Q4 FY21 revenue (and y/y revenue growth) by service line was:

  • IT services: $1,223m (+10.2%)
  • BPO services: $161m (+63.7%).

Headcount at the end of Q1 FY22 was 126,263, up 2.3% y/y. The breakdown was:

  • Software professional: 69,877 (-1.6% y/y)
  • BPO professionals: 49,668 (+9.0%)
  • Sales & support: 6,718 (-1.8%).

Attrition was 17% (Q1 FY21: 17%). Utilization rate was 88% (Q` FY21: 82%).

 

VendorTech Mahindra
Initial currency type (specify local currency used)US$
Period Ending2021-06-30
Growth2.7
Revenues ((m) in local currency1384
Revenues (in $m at that date)1384

Rate this article

rate this
No votes
close